Assessing the impact of alternative patent systems on the cost of health care: the TPPA and HIV treatment in Vietnam

HVJ Moir, B Tenni, D Gleeson… - Asia-Pacific Innovation …, 2014 - papers.ssrn.com
Abstract In the Trans Pacific partnership Agreement (TPPA) negotiations, the United States
has proposed expanded patent protections that will likely impact the affordability of …

Patents and access to antiretroviral medicines in Vietnam after World Trade Organization accession

J Kuanpoth - The Journal of World Intellectual Property, 2007 - Wiley Online Library
Antiretroviral (ARV) drugs, where they are accessible, have been shown to prolong the lives
and increase the health and well‐being of people living with human immunodeficiency …

The trans Pacific partnership agreement and access to HIV treatment in Vietnam

HVJ Moir, B Tenni, D Gleeson, R Lopert - Global Public Health, 2018 - Taylor & Francis
ABSTRACT In the Trans Pacific Partnership (TPP) Agreement negotiations, the USA
successfully pursued intellectual property (IP) provisions that will affect the affordability of …

Patents and the trans-Pacific partnership: how TPP-style intellectual property standards may exacerbate the access to medicines problem in the east African …

O Owoeye, O Olatunji, B Faturoti - The International Trade Journal, 2019 - Taylor & Francis
Least developed countries (LDCs) generally enjoy some exemptions under the WTO TRIPS
Agreement. Despite these exemptions, patents continue to pose a major challenge to …

[HTML][HTML] Projected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP)

S Juneja, A Gupta, S Moon, S Resch - PloS one, 2017 - journals.plos.org
The Medicines Patent Pool (MPP) was established in 2010 to ensure timely access to low-
cost generic versions of patented antiretroviral (ARV) medicines in low-and middle-income …

[图书][B] Introducing government use of patents on essential medicines in Thailand, 2006-2007 Policy analysis with key lessons learned and recommendations

S Tantivess, N Kessomboon, C Laongbua - 2008 - 164.115.27.97
Intellectual property rights protection has two important roles in public health. On the positive
side, this legislation framework aims to promote medicine discovery and innovation through …

[PDF][PDF] Pharmaceutical patents, developing countries and HIV/AIDS research

E Combe, E Pfister, P Zuniga - Economics of AIDS and access to …, 2003 - researchgate.net
Patents are one of the reasons why many patients from developing countries lack access to
AIDS treatments. The usual justification for implementing patent systems in the third world …

A method for understanding generic procurement of HIV medicines by developing countries with patent protection

RF Beall, A Attaran - Social Science & Medicine, 2017 - Elsevier
Patent protection on medicines may frustrate access by blocking generic competition.
Nevertheless, circumstances may still allow for generic procurement to occur anyway …

Re-visiting the patents and access to medicines dichotomy: An evaluation of TRIPS implementation and public health safeguards in developing countries

T Amin - The Global Governance of HIV/AIDS, 2013 - elgaronline.com
One of the key concerns surrounding the Agreement on Trade-Related Aspects of
Intellectual Property Rights (TRIPs) was its potential impact on access to medicines (Correa …

[HTML][HTML] Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States

KB Son, R Lopert, D Gleeson, TJ Lee - Globalization and health, 2018 - Springer
Background The inclusion of patent linkage mechanisms in bilateral and plurilateral trade
and investment agreements has emerged as a key element in the United States' TRIPS-Plus …